Literature DB >> 2248116

Determinants of neuropsychological impairment in antisocial substance abusers.

P Malloy1, N Noel, R Longabaugh, M Beattie.   

Abstract

Persons displaying Antisocial Personality Disorder (ASP) may be at risk for neuropsychological impairment due to a number of developmental and later life experiences to which they are prone. Thirty substance abusers meeting research criteria for ASP were compared to a demographically matched non-ASP cohort on neuropsychological test performance. The ASP subjects were found to have a higher prevalence of neuropsychological deficit. The groups were then compared on factors which might lead to brain impairment. Presence of ASP was associated with earlier and heavier past drinking patterns, more negative health and behavioral effects of alcohol abuse, and greater abuse of other drugs in addition to alcohol. The ASP alcoholics also reported a high prevalence of serious head injury (58%), although they did not differ from non-ASP alcoholics in this regard. Implications for the neuropsychology of alcoholism and for treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2248116     DOI: 10.1016/0306-4603(90)90029-w

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  3 in total

Review 1.  Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.

Authors:  Tomas Palomo; R M Kostrzewa; R J Beninger; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Relationship between personality disorder dimensions and verbal memory functioning in a community population.

Authors:  Subin Park; Jin Pyo Hong; Hochang B Lee; Jack Samuels; O Joseph Bienvenu; Hye Yoon Chung; William W Eaton; Paul T Costa; Gerald Nestadt
Journal:  Psychiatry Res       Date:  2012-02-16       Impact factor: 3.222

Review 3.  Alcohol, head injury, and neuropsychological function.

Authors:  D A Solomon; P F Malloy
Journal:  Neuropsychol Rev       Date:  1992-09       Impact factor: 7.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.